Tech News Point

Creative Biolabs Is a Leading Service Provider of In Vitro Diagnostics

 Breaking News
  • No posts were found

Creative Biolabs Is a Leading Service Provider of In Vitro Diagnostics

September 06
19:12 2019
Creative Biolabs offers comprehensive in vitro diagnostic development relative services to help international customers to explore the galaxy of diagnostic antibodies and accelerate every possible project process.

Sep 6, 2019 – New York, US –

Introduction of In Vitro Diagnostics (IVD)

In Vitro Diagnostics refer to the tests applied for detection and diagnosis of diseases, infections or other medical changes (health status checking), so as to cure, mitigate, treat, or prevent disease or its sequelae, which are intended applicable in disease screening, infections detecting, therapeutic monitoring, ensuring blood is safe to be used in transfusions, and recognizing of allergies and the measurement of hormones and other biological markers in body specimen.

Creative Biolabs, targeting at the crucial equipment in the medical research and pharmaceutical manufacturing domains, launches comprehensive services and In Vitro Diagnostic (IVD) Antibodies, supported by a group of experienced scientists and advanced antibody development platforms. The full set of services cover almost the 8 major systems of human body, ranging from autoimmune diseases, cancers, infectious diseases, cardiovascular illnesses to hormone disorders.

Targeting at the Autoimmune Diseases Biomarkers

Malfunctions in the immune system of human body may result in the loss of competence of discriminating the self and non-self cells, and thus causing the “internal conflicts” among cells. The provided one-stop diagnostic immunoassay development solutions including feasibility analysis, assay design, assay protocol establishment, validation, and production processes are intended for autoimmune diseases and ensured for the first-level standard outcomes. The yet developed immunoassays touch upon the diseases like rheumatoid arthritis, systemic lupus erythematosus, childhood asthma and mucous membrane pemphigoid, etc.

Targeting at the Biomarkers of Cancers

Evolved from the conventional methods for cancer diagnosis that compose blood, urine test, CT, MRI, the IVD solutions in Creative Biolabs focus on the detection of cancer biomarkers, with methods like ELISA, LFFIA, CLIA and IHC adopted. Equipped with the rich experience in the generation of high-quality antibody (pairs) for the development of novel IVD immunoassays targeting various diagnostic biomarkers of cancer, the available services penetrate through all-round tumor categories like pancreatic cancer, brain cancer, leukemia, gastrointestinal cancer, thyroid cancer and et al.

The comprehensive IVD antibody development services, as usual, can be modified catering to specific needs and accept both established and new biomarkers as repertoire.

Other disease-focused IVD services are also accessible if needed. To satisfy every order’s requirements, Creative Biolabs offers some other tailored follow-up operations, containing easibility analysis, assay design, assay protocol establishment, validation, and production, etc. A further visit at https://www.creative-biolabs.com/drug-discovery/diagnostics/ will help obtain more useful information.

About the Company

Creative Biolabs was founded in 2004 by a group of scientists dedicated a wide scope of diseases treatment. It is believed that the establishment of a custom-service-centered business model will become the key point for perfecting the process of medicine research and development, leveraging accessible resources and gathering a team from various backgrounds to conduct drug discovery projects in the future.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/drug-discovery/diagnostics/